Kevin M. Koch
Jagiellonian University(PL)Hospital for Special Surgery(US)Medical College of Wisconsin(US)Paderborn University(DE)Nivalis Therapeutics (United States)(US)München Klinik Neuperlach(DE)Reynolds American (United States)(US)Villanova University(US)
Publications by Year
Research Areas
Advanced MRI Techniques and Applications, HER2/EGFR in Cancer Research, Advanced Neuroimaging Techniques and Applications, Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Phase I Safety, Pharmacokinetics, and Clinical Activity Study of Lapatinib (GW572016), a Reversible Dual Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinases, in Heavily Pretreated Patients With Metastatic Carcinomas(2005)622 cited
- → Biological Characterization of ARRY-142886 (AZD6244), a Potent, Highly Selective Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor(2007)582 cited
- → Metal-Induced Artifacts in MRI(2011)542 cited
- → Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies(2005)364 cited
- → Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis.(1995)317 cited
- → A multispectral three‐dimensional acquisition technique for imaging near metal implants(2009)265 cited